1. Basu, P., Joglekar, G., Rai, S., Suresh, P., & Vernon, J. (2008). Analysis of manufacturing Costs in Pharmaceutical Companies. Drug Information Journal, 3, 30–40.
2. Baum, A. S. (2015, February). Citi Investor Report.
3. Coda Corp USA. (2010). Proactive agency initiatives promote the development of treatments for rare diseases. New York: Coda Corp USA.
4. Ernst & Young. (2012). Progressions. Global Life Sciences Report. 49.
5. EvaluatePharma. (2012). World preview—embracing the patent cliff. London UK: EvaluatePharma.